Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Katarina Gabrielson appointed as CEO of Oriola

Oriola Corporation Insider information 10 May 2022 at 9:00 a.m. Katarina Gabrielson appointed as CEO of Oriola Oriola Corporation’s Board of Directors has appointed Ms. Katarina Gabrielson (M.Sc., Swedish citizen) as CEO starting from 10 May 2022. Katarina Gabrielson is currently working as interim CEO and Vice President of the company’s B2B business in Sweden. She has been working in various Director positions at Oriola since 2012. “The Board of Directors commenced the recruitment process immediately after Elisa Markula’s resignation in February 2022. After careful evaluation, I

Proact enhances networking services offering with software-defined managed services package “SD-Connect”

By adding SD-Connect – comprised of SD-WAN, SD-WiFi and SD-LAN – to its portfolio, Europe’s leading independent data centre and cloud services provider Proact is able to offer its customers an AI-driven networking solution. The improved network performance made possible by these services is critical for enabling access to data wherever it is stored.The services that make up SD-Connect are designed to interoperate with one another to ensure ideal network coverage. They are additionally delivered from the same vendor, resulting in a more consistent service than a mixture of networking

Relais Group Plc: Increase in the number of shares registered in the trade register

Relais Group Plc, Company Release 10 May 2022 at 9.00 a.m. EET In order to meet the terms and conditions related to the acquisition of Lumise Oy completed on 31 March 2021, Relais Group Plc issued a total of 64,407 new shares on 25 April 2022 in a directed free share issue. The shares have been entered in the Finnish Trade Register on 10 May 2022. The new shares will carry the right to receive dividends and other distribution of funds, if any, and other shareholder rights in Relais Group Plc as of the registration of the shares in the Finnish Trade Register. Relais Group Plc now has a

Veg of Lund AB: Interim Report January - March 2022

Proactive efforts to drive salesJanuary–March 2022 · Net sales amounted to TSEK 455 (84). · Operating profit before depreciation and amortization (EBITDA) amounted to TSEK -17 712 (-2,164), and EBIT amounted to TSEK -17,764 (-2,282). · Net profit amounted to TSEK -17,999 (-2,270). Significant events January–March 2022 · An extraordinary general meeting held on 31 January 2022 elected two new members to the Board of Directors: Magnus Nordin and Håkan K Pålsson. Håkan K Pålsson was elected Chairman of the Board. · UK food companies choose DUG[®] for vegetarian and vegan

SciBase to present at the Redeye Medtech & Diagnostics Seminar on May 11, 2022

SciBase a leading developer of augmented intelligence-based solutions for skin disorders, announced today that CEO Simon Grant will present an update on the latest developments from SciBase at the Redeye Medtech & Diagnostics seminar on May 11[th] at 10.55 pm. The presentation will be followed by a short Q&A. The presentations are live broadcasted at https://www.redeye.se/events/825143/redeye-theme-medtech-diagnostics . The presentation will also be available at www.redeye.se and on the Company's website i n Redeye Universe.“It has been a busy start to the year and we see an exciting year

Saga Pure: First quarter 2022 financial results

(Oslo, 10 May 2022) Saga Pure ASA (Saga Pure, OSE: SAGA) reported a net profit in the first quarter 2022 of NOK 53.6 million (Q1 2021: NOK 147.8 million), corresponding to a year-to-date return on equity of 5 percent.“During the first quarter of 2022, we have witnessed volatile markets. We thus continue to be selective in our investment approach and focus on further developing the companies in our portfolio. We still have strong conviction of our portfolio companies, supported by our increased exposure in Bergen Carbon Solutions and Horisont Energi during the quarter. We hold a significant

Rapid sales growth and a strong start to the year

First quarter 2022 · Net revenue increased by 65% to SEK 756 million (457). Organic growth was 7%. · Adjusted EBITA increased to SEK 88 million (73), corresponding to a margin of 11.6% (15.9). · Profit for the period totalled SEK 33 million (32) and earnings per share, basic and diluted, amounted to SEK 0.24 (1.29). · Adjusted earnings per share, basic and diluted, totalled SEK 0.32 (1.40). · Cash flow from operating activities amounted to SEK 76 million (111). · On 1 January, the acquisitions were completed of German company Zentrale Autoglas GmbH, which operates a bus

Hexagon Purus ASA: Results for the first quarter 2022

Hexagon Purus delivered robust year-over-year revenue growth in Q1 2022 coupled with strong commercial momentum across the business.   Q1 2022 highlights: · Revenue grew 209% year-over-year to NOK 159 million, including NOK 107 million contribution from Wystrach. Organic revenue on a standalone basis (i.e., as if Wystrach were an external customer in Q1 2022) was NOK 84 million, representing organic year-over-year growth of approximately 63% · Signed a long-term binding letter of intent with Hino Motors Manufacturing U.S. and nominated by another leading, established commercial

Interim report Q1: Higher growth and stronger margin despite uncertain times

January – March 2022 · Net sales increased with 89 % and amounted to SEK 632 (334) million. · Organic growth amounted to 29 (19) %. · Adjusted EBIT increased to SEK 22 (7) million with a margin of 3.5 (2.1) %. · Profit for the period amounted to SEK 10 (3) million. · Earnings per share for the period before and after dilution amounted to SEK 0.19 (0.24). “This year’s first quarter continued to prove strong growth and profit development. Our adjusted EBIT margin amounted to 3.5 % which represents a clear improvement measured against the comparable period (2.1). During the

Aker Carbon Capture ASA: Mandatory notification of trade as Aker Horizons increases stake in ACC through sale of Rainpower to AKSO

Reference is made to the respective announcements by Aker Horizons ASA (“Aker Horizons”) and Aker Solutions ASA (“AKSO”) on 30 March 2022 regarding AKSO’s purchase of 100 percent of the shares in Rainpower Holding AS from a subsidiary of Aker Horizons (the “Transaction”).The agreed consideration for the Transaction consists of two elements: a fixed element of NOK 100 million and a discretionary element of up to NOK 50 million. The fixed element is agreed to be settled by transfer of 5,681,818 shares in Aker Carbon Capture ASA (“ACC”). The conditions to the Transaction have been satisfied.

Bravida Denmark to install complete technical solutions for AGC Biologics A/S with an order value of approximately DKK 150 million

Bravida Denmark has signed a contract with AGC Biologics A/S to carry out all the technical installation work for a new 18,000 square metre building in Søborg.AGC Biologics A/S will include production facilities, quality laboratories, storage areas and cargo space. The building also contains offices, a customer centre and a basement with storage and parking. Bravida’s assignment includes ventilation, water, wastewater, heating, cooling (excluding the central cooling facility), building electricity, IT infrastructure, security, BMS and sprinklers. Bravida will also supply solar cells for the

Pagero launches support for P27 to help Nordic companies meet future requirements

Pagero announces that its e-banking service now supports P27, the new payment platform that will replace BankgirotFrom 2023, Bankgirot will be phased out as platform for payments between companies in the Nordic region. Bankgirot will be replaced by P27 Nordic Payments Platform, a new payment infrastructure for the Nordics developed in a joint initiative by Danske Bank, Handelsbanken, Nordea, OP Financial Group, SEB and Swedbank. The goal is to offer a simpler and more future-proof payment infrastructure for companies and individuals in the Nordic region. Pagero, which for over a decade

HKScan’s EBIT down on the comparison period as expected, with the outlook for 2022 unchanged

HKScan Corporation, January-March Interim Report, 10 May 2022 at 8.30 a.m. EETHKScan’s Interim Report 1 January – 31 March 2022  HKScan’s EBIT down on the comparison period as expected, with the outlook for 2022 unchanged January-March 2022 · HKScan’s net sales totalled EUR 437.2 (427.5) million. In comparable figures, net sales increased by almost four per cent. Net sales increased in all the company’s home markets. Clear increase in food service sales and retail sales of meals and meal components.  · The Group’s EBIT totalled EUR -8.9 (-1.1) million.  · The Group’s

Musti Group plc Half-Year Financial Report 1 October 2021 – 31 March 2022

Musti Group plc                Half-Year Financial Report              10 May 2022 at 8:30 a.m. EEST Musti Group plc Half-Year Financial Report 1 October 2021 – 31 March 2022 Solid first half – on track with the long-term targets January – March 2022 · Group net sales totalled EUR 92.4 million (82.4 million), an increase of 12.1%. · Like-for-like sales growth was 4.5%. · Adjusted EBITDA was EUR 14.0 (13.1) million, up by 6.5%. · Adjusted EBITDA margin was 15.1% (15.9%). · Adjusted EBITA was EUR 7.0 (7.7) million, down by 9.2%. · Adjusted EBITA margin was 7.6% (9.

RevolutionRace continues to grow globally – net sales increased by 50 percent to SEK 367.4 million and EBIT by 61 percent to SEK 103.5 million in the third quarter

“It brings me both satisfaction and pride that RevolutionRace continues to gain market share globally. Net sales in the third quarter increased by 50 percent to SEK 367.4 million, and gross profit rose to SEK 268.5 million, corresponding to a gross margin of 73.1 percent. Operating profit (EBIT) rose by 61 percent to SEK 103.5 million with a strengthened EBIT margin amounting to 27.0 percent. With our strong financial position, operational implementation capability, digital positioning and brand, RevolutionRace continues to grow rapidly in existing and recently launched markets,” says

New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register

OPTOMED PLC     STOCK EXCHANGE RELEASE 10 May 2022, at 8.30 EEST   New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register A total of 1,397,853 new shares subscribed for in Optomed Plc’s directed share issue have been registered into the Finnish Trade Register today, on 10 May 2022. After the registration of the new shares, the company will have 15,400,997 shares in total of which 386,517 shares in treasury.   The new shares produce the right to dividends and other distribution of assets as well as other shareholder

RevolutionRace publishes updated financial calendar for 2022/2023

RVRC Holding AB (publ) publishes its financial calendar for the financial year 2022/2023 and updates the date of publication of the year-end report 2021/2022 and the interim report for the second quarter.The financial reports will be published at 07:30 CET followed by a webcasted press and analyst conference in the morning. RevolutionRace fiscal year runs from July 1 to June 30. Financial reportingYear-end report 2021/2022 - August 16, 2022 (previous August 9, 2022)Interim report, Q1 - November 8, 2022Interim report, Q2 - January 31, 2023 (previous February 7, 2023)Interim report,

NOHO PARTNERS PLC’S INTERIM REPORT 1 JANUARY–31 MARCH 2022: Restaurant demand recovery faster than expected – the company expects its turnover to increase to approximately MEUR 300 already this year

NoHo Partners PlcINTERIM REPORT 10 May 2022 at 8:15 a.m.NOHO PARTNERS PLC’S INTERIM REPORT 1 JANUARY–31 MARCH 2022 Restaurant demand recovery faster than expected – the company expects its turnover to increase to approximately MEUR 300 already this year JANUARY–MARCH 2022 IN BRIEFEntire Group · Turnover increased by 140.6% to MEUR 48.5 (MEUR 20.2).  · EBIT increased by 86.6% to MEUR -1.3 (MEUR -9.7).  · The EBIT percentage was -2.7% (-48.3%). · The result for the financial period was MEUR -3.6 (MEUR -10.8), an increase of 66.9%.  · Earnings per share were EUR -0.

Noreco Announces First Quarter 2022 Results

Oslo, 10 May 2022: Norwegian Energy Company ASA ("Noreco" or the "Company") today announced its first quarter 2022 results. The quarter delivered both strong production of 28.5 mboepd and financial results with revenues of USD 179 million and EBITDA of USD 107 million.  Highlights: •    Hydrocarbon production of 28.5 mboepd•    Total Revenues of USD 179 million, which compares to USD 105 million in Q1 2021•    EBITDA of USD 107 million, compared to USD 29 million in the same period in 2021•    Net cash flow of USD 87 million and cash on balance sheet of USD 147 million  Net

Software company from Silicon Valley employs in Gothenburg

The West Swedish mobility cluster attracts the California software company Apex-AI to establish in Gothenburg. The company supplies operating systems for the development of secure and scalable software for vehicles and systems for autonomous driving. The team in Gothenburg is expected to grow rapidly.Apex-AI has chosen Sweden to get closer to existing and potential customers in northern Europe, and to gain better access to Swedish know-how and expertise. “I am incredibly pleased to welcome a Swedish team to the Apex.AI family,” says Jan Becker, CEO of Apex-AI. In addition to the head

Interim Report 3 months – 1 January-31 March 2022

FIRST QUARTER (1 JAN-31 MAR 2022) · Net sales increased by 16 percent to SEK 1,773 million (1,523), of which currency-adjusted sales rose by 12 percent. · Operating profit before depreciation and amortisation (EBITDA) excluding non-recurring items of SEK -11 million (-14) amounted to SEK 175 million (179). 1) · Operating profit amounted to SEK 92 million (102) and the operating margin was 5.2 percent (6.7). Operating profit was charged with non-recurring items of SEK -21 million (-14). 1) · Profit after financial items totalled SEK 87 million (69). · Profit after tax

Nordic Outlook: War and inflation will hamper growth

The global growth outlook has been lowered significantly since the outbreak of the Ukraine war, while inflation forecasts have been revised upward. Russia's invasion of Ukraine will have serious consequences for both consumers and producers for years to come, and energy prices will remain high. Central banks will implement a number of interest rate hikes in the near future to instil confidence in their inflation targets. We have sharply lowered our Swedish GDP growth forecast, as households are being squeezed by high inflation and rising interest rates. The Riksbank is facing a difficult

Invitation to the publication of Toivo Group Plc’s Business Review for January–March 2022

Press release, 10 May 2022 at 8:00 Toivo Group Plc is organising an analyst and media event in conjunction with the business review for January–March 2022 on Wednesday, 11 May 2022 at approximately 11:00. The business review will be presented as an audio webcast. The company announcement regarding the business review will be published on the same day at approximately 8:30. The results will be presented by Toivo Group’s CEO Markus Myllymäki and CFO Samuli Niemelä. The event will be held in Finnish. Time: Wednesday, 11 May 2022 at 11:00 Webcast link:  https://toivo.videosync.fi/

Moberg Pharma begins patient enrollment in North American phase 3 study

Moberg Pharma AB (OMX: MOB) today announced that patient enrollment has started in the North American Phase 3 study for MOB-015 (nail fungus treatment).The randomized, multicenter, vehicle-controlled Phase 3 study will include approximately 350 patients in North America. The patients will be evaluated over 52 weeks and the primary endpoint will be the proportion of subjects achieving complete cure of their target nail. The study design builds on the experience gained from the previous Phase 3 studies. Moberg Pharma will cooperate with the same CRO, lead investigator and successful sites

There are no items matching the current filter
There are no more items matching the current filter
Back to top